NEUROFIBROMA, PLEXIFORM
Clinical trials for NEUROFIBROMA, PLEXIFORM explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMA, PLEXIFORM trials appear
Sign up with your email to follow new studies for NEUROFIBROMA, PLEXIFORM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new drug TURALIO tested in kids with tough cancers
Disease control Recruiting nowThis early-stage study tests a drug called TURALIO (pexidartinib) in people aged 3 to 35 whose cancer (like leukemia or solid tumors) has not responded to standard treatments. The main goal is to find a safe dose and see if it can shrink tumors or stop them from growing. Particip…
Matched conditions: NEUROFIBROMA, PLEXIFORM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
New pill could shrink nerve tumors in NF1 patients
Disease control Recruiting nowThis early-stage trial tests an experimental drug called PAS-004 in adults with neurofibromatosis type 1 (NF1) who have at least one symptomatic, inoperable nerve tumor (plexiform neurofibroma). The study aims to find safe doses and check for side effects. Participants take a dai…
Matched conditions: NEUROFIBROMA, PLEXIFORM
Phase: PHASE1 • Sponsor: Pasithea Therapeutics Corp. • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
Korean study tracks Koselugo's Real-World impact on rare nerve tumors
Knowledge-focused Recruiting nowThis study is observing 200 people in South Korea who are already prescribed Koselugo for neurofibromatosis type 1 (NF1) with plexiform neurofibromas. Researchers will track side effects and how well the drug works in everyday medical practice. The goal is to confirm the drug's s…
Matched conditions: NEUROFIBROMA, PLEXIFORM
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:50 UTC